Orgasm-associated urinary incontinence (climacturia) following radical prostatectomy: a review of pathophysiology and current treatment options.

Mini-Jupette graft climacturia male urethral sling orgasm-associated urinary incontinence prostate cancer radical prostatectomy

Journal

Asian journal of andrology
ISSN: 1745-7262
Titre abrégé: Asian J Androl
Pays: China
ID NLM: 100942132

Informations de publication

Date de publication:
Historique:
pubmed: 14 3 2020
medline: 23 9 2021
entrez: 14 3 2020
Statut: ppublish

Résumé

Orgasm-associated urinary incontinence, or climacturia, is a common side effect after radical prostatectomy (RP) that is gaining more attention due to the distress it causes to patients. A range of treatment options have been reported in the literature and are outlined in this review. The goal of our study is to review the pathophysiology and current management options for climacturia following RP. A PubMed search was used to review the current literature relating to the pathophysiology and the treatment of postprostatectomy climacturia. We reviewed the currently available treatment options and their success rates for climacturia. Several techniques were found to subjectively help improve the amount and bother of patients' climacturia. These include pelvic floor muscle training (PFMT), penile variable tension loop, soft silicone occlusion loop, artificial urethral sphincter, male urethral sling, and the Mini-Jupette graft. Success rates ranged from 48% to 100% depending on the modality used. For patients with erectile dysfunction and climacturia, the Mini-Jupette graft could be a valuable option. Given the lack of validated measurement tools and management options, climacturia has become a challenge for urologists. Albeit a condition that has not garnered much attention, there are several management options from conservative to invasive treatments that have shown a hopeful promise for the treatment of climacturia. These options should be discussed with patients to determine the best treatment for each individual. More clinical trials are needed to assess the efficacy and impact of the different treatment options before a definitive recommendation regarding management can be made.

Identifiants

pubmed: 32167075
pii: 279391
doi: 10.4103/aja.aja_145_19
pmc: PMC7705983
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

549-554

Déclaration de conflit d'intérêts

None

Références

J Sex Med. 2012 Aug;9(8):2150-6
pubmed: 22759835
J Sex Med. 2014 Sep;11(9):2318-26
pubmed: 24995845
J Sex Med. 2009 Dec;6(12):3496-9
pubmed: 20092471
Sex Med Rev. 2018 Jan;6(1):124-134
pubmed: 29108976
J Urol. 2014 Jan;191(1):159-63
pubmed: 24050893
World J Mens Health. 2017 Apr;35(1):1-13
pubmed: 28459142
Br J Urol. 1996 Jun;77(6):861-4
pubmed: 8705222
Int J Impot Res. 2011 Mar-Apr;23(2):81-6
pubmed: 21471982
J Urol. 2006 Dec;176(6 Pt 1):2562-5; discussion 2565
pubmed: 17085160
J Urol. 2007 Jun;177(6):2223-6
pubmed: 17509325
J Urol. 2000 Jun;163(6):1767-70
pubmed: 10799178
BJU Int. 2004 Sep;94(4):603-5
pubmed: 15329121
J Sex Med. 2019 Aug;16(8):1310-1317
pubmed: 31109775
J Clin Oncol. 2011 Jan 10;29(2):235-41
pubmed: 21135285
Sex Med Rev. 2018 Jan;6(1):16-28
pubmed: 28941806
J Natl Cancer Inst. 2009 Oct 7;101(19):1325-9
pubmed: 19720969
Int J Impot Res. 2016 Jan-Feb;28(1):9-13
pubmed: 26538105
J Sex Med. 2018 May;15(5):789-796
pubmed: 29523479
BJU Int. 2013 Mar;111(3):500-4
pubmed: 22672308
Neurourol Urodyn. 2016 Nov;35(8):875-881
pubmed: 26397171
BJU Int. 2012 Apr;109(8):1208-12
pubmed: 21895932
J Sex Med. 2011 Sep;8(9):2632-9
pubmed: 21699660
Urology. 2014 Aug;84(2):433-8
pubmed: 24972946
J Urol. 2011 Sep;186(3):982-5
pubmed: 21791358
Transl Androl Urol. 2017 Feb;6(1):2-11
pubmed: 28217445
Sex Med Rev. 2018 Jul;6(3):429-437
pubmed: 29396282
BJU Int. 2005 Sep;96(4):472-4
pubmed: 16104892
BJU Int. 2017 Apr;119(4):626-630
pubmed: 27862836
Eur Urol. 2012 Aug;62(2):273-86
pubmed: 22575910

Auteurs

Christopher Kannady (C)

Division of Urology, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

Jonathan Clavell-Hernández (J)

St. Joseph Medical Center, Houston, TX 77002, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH